Who Paid My Doc
M14-033
ClinicalTrials.gov NCT02065622
Research payments
$739,419
Through program year 2020, $739,419 in research payments was reported against M14-033, across 174 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02065622
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $333,821 | 27 |
| 2019 | Research | $405,599 | 147 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Harry Sarles Rockwall, TX Named on 17 payments
- Humberto Aguilar Shreveport, LA Named on 16 payments
- Daniel Geenen Milwaukee, WI Named on 12 payments
- Ashwin Ananthakrishnan Boston, MA Named on 11 payments
- Amy Devlin Boston, MA Named on 11 payments
- Blair Lewis New York, NY Named on 11 payments
- Alan Safdi Cincinnati, OH Named on 10 payments
- Eugene Greenberg Urbana, IL Named on 10 payments
- Javier Sobrado Miami, FL Named on 9 payments
- James Marion New York, NY Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.